APLT — Applied Therapeutics Balance Sheet
0.000.00%
- $16.93m
- $4.98m
- $0.46m
Annual balance sheet for Applied Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 96.8 | 80.8 | 30.6 | 50.2 | 79.4 |
| Prepaid Expenses | |||||
| Total Current Assets | 103 | 88.4 | 37.3 | 54.4 | 83.6 |
| Net Property, Plant And Equipment | 1.71 | 1.3 | 0.857 | 0.447 | 2.79 |
| Other Long Term Assets | |||||
| Total Assets | 105 | 89.9 | 38.4 | 54.8 | 86.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 21.2 | 26.5 | 33.4 | 71.2 | 27.3 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 22.6 | 27.4 | 34.3 | 72 | 29.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 81.9 | 62.5 | 4.06 | -17.1 | 57 |
| Total Liabilities & Shareholders' Equity | 105 | 89.9 | 38.4 | 54.8 | 86.7 |
| Total Common Shares Outstanding |